Alyeska Investment Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-536,847
Closed -$2.08M 966
2020
Q4
$2.08M Buy
536,847
+45,706
+9% +$195K 0.03% 369
2020
Q3
$1.98M Buy
491,141
+139,716
+40% +$579K 0.03% 356
2020
Q2
$1.5M Buy
+351,425
New +$2.14M 0.02% 374
2020
Q1
Sell
-643,444
Closed -$2.53M 567
2019
Q4
$2.53M Buy
+643,444
New +$3.8M 0.03% 280
2019
Q2
Sell
-315,910
Closed -$2.03M 589
2019
Q1
$2.03M Buy
+315,910
New +$2.06M 0.03% 284
2018
Q4
Sell
-125,000
Closed -$2.52M 573
2018
Q3
$2.52M Buy
125,000
+75,000
+150% +$1.96M 0.03% 285
2018
Q2
$1.46M Buy
50,000
+28,925
+137% +$893K 0.01% 373
2018
Q1
$628K Buy
+21,075
New +$680K 0.01% 412
2017
Q3
Sell
-80,583
Closed -$2.4M 613
2017
Q2
$2.4M Buy
80,583
+5,583
+7% +$160K 0.02% 334
2017
Q1
$2.24M Buy
+75,000
New +$1.91M 0.02% 392

Other funds holding LJPC